New data published by the UK Health Security Agency (UKHSA) has revealed that London is potentially at risk of a measles resurgence.
UKHSA modelling suggests that, unless MMR vaccination rates improve, London could see a measles outbreak with tens of thousands of cases.“Those who have never received a measles vaccine (MMR) are at risk,” said UKHSA.MMR is part of the NHS Routine Childhood Immunisation Programme. Parents whose infants missed out, or anyone of any age unvaccinated, are urged to come forward.Susceptibility is particularly high among 19 to 25 year olds, affected by unfounded stories in the early 2000s (‘Wakefield cohorts’) and some may still not be fully vaccinated.As part of continued efforts to protect people against getting measles, the NHS is launching a campaign encouraging people to check their vaccination status, with targeted outreach to groups in London.Data published today by the UK Health Security Agency (UKHSA) shows there has been a steady rise in measles cases this year. It shows, between 1 January and 30 June this year there have been 128 cases of measles, compared to 54 cases in the whole of 2022, with 66 per cent of the cases detected in London although cases have been seen in all regions.The UKHSA assessment finds the risk of a measles epidemic across the UK is considered low. However, with lower current levels of coverage in London, a measles outbreak of between 40,000 and 160,000 cases could occur in the capital.The assessment also concludes that there is a high risk of cases linked to overseas travel leading to outbreaks in specific population groups such as young people and under-vaccinated communities.The risk in London is primarily due to low vaccination rates over several years, further impacted by the COVID-19 pandemic, particularly in some areas and groups where coverage of the first MMR dose at 2 years of age is as low as 69.5%.NHS England has launched a targeted national campaign to encourage uptake of the MMR vaccine, including targeted outreach work in London for those identified as at high risk and communities with the lowest uptake of vaccination.Search
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Related News
More For You
Pharmacies in line to roll out NHS weight loss jabs
May 02, 2025
Pharmacies are “best placed” to deliver a planned rollout off greater access to weight loss jabs which could benefit 3.4 million people in England.
Reports today claim the government is looking at trials that would see the medication made available following a short, over-the-counter consultation for the price of an NHS prescription.
Currently weight loss drugs such as Mounjaro and Wegovy are prescribed to patients after being referred to specialist weight loss clinics, which are usually located in hospitals.
However, at the moment, there is a two-year waiting list for Wegovy on the NHS with report claiming the rollout of the NHS service is taking longer than expected.
Pharmacies already sell the medication as a private service with costs ranging between £120 and £250 for a month's supply.
According to the Daily Mail, a multimillion-pound deal for a pilot scheme will be struck with a pharmaceutical firm, with a view to issuing prescriptions through pharmacies and health centres.
“Pharmacies stand ready and able to deliver this service,” Olivier Picard, chairman of the National Pharmacy Association (NPA), said on Radio 4’s Today programme.
“Access to medicines that could cut damaging levels of obesity shouldn’t be restricted to those who can pay or disadvantage deprived communities.
“We’re yet to see the detail but this announcement has the potential to make sure that people who need these treatments the most could access them for free.”
Picard added that pharmacists have the clinical expertise to oversee the safe usage of weight loss drugs to tackle “an obesity crisis in the country”.
“Pharmacies are the most accessible part of the NHS, and there are many pharmacies in deprived areas despite recent challenges,” he said.
“Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care including lifestyle advice.
“They are best placed to help roll this treatment out on the NHS, with the right funding support.”
A Government spokesperson added: “As the Government shifts the NHS from sickness to prevention, we will be looking across the board at how these drugs can be made available to more people who can benefit from them.
“The NHS is already tackling obesity in innovative ways, including through community care models and digital technologies, to help deliver these drugs as part of a rounded package of care.”
Keep ReadingShow less
Most Popular
Don’t Miss Out
Get the latest updates and insights delivered to your inbox.
The H Human Medicines Regulations amendments will come into force on 1 October 2025.
Image credit: Getty Images
Hub and spoke dispensing between separate pharmacy businesses to begin in October
May 02, 2025
Community Pharmacy England (CPE) has confirmed that the government has laid amendments to the Human Medicines Regulations 2012 (HMR) in Parliament, marking a crucial step towards enabling hub and spoke dispensing between separate community pharmacy businesses.
The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 are set to come into force on 1 October 2025.
However, as pharmacies are required to notify their Integrated Care Board (ICB) at least 28 days before commencing hub and spoke dispensing for NHS prescriptions, the earliest possible implementation date would be 29 October 2025.
Currently, hub and spoke dispensing is only permitted between community pharmacies owned by the same legal entity (the same retail pharmacy business).
These new regulatory changes will, for the first time, allow independent pharmacies (different retail pharmacy owners) to carry out hub and spoke dispensing under Model 1 – where medicines are assembled by the hub and returned to the spoke pharmacy for supply to the patient (patient – spoke – hub – spoke – patient).
Model 2, where the hub pharmacy supplies medicines directly to the patient (patient – spoke – hub – patient), will not be introduced due to patient safety and regulatory concerns.
Harry McQuillan, chairman of Numark, described the government's announcement as “a welcome move toward enabling greater flexibility and efficiency in community pharmacy.”
He noted that while the operational model is now broadly understood, the economic model remains unclear, and “that will be critical in determining how this change will truly benefit the sector.”
"At Numark, we are actively exploring how this legislation could open up opportunities for our members.”
“We are working to evaluate solutions that could support them to access the benefits of scale, while maintaining their local presence and patient relationships.”
"As always, the detail will be key,” he added.
He stressed that it is essential for the regulatory and economic frameworks to align in order to offer genuine, practical advantages to the sector.
Meanwhile, the CPE continues discussion with the Department of Health and Social Care (DHSC) for further amendments to the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations (PLPS).
These will enable NHS spoke pharmacies to subcontract part of the NHS Essential Dispensing Service to the hub.
Key points of the HMR amendments include:
- Written agreements must be in place between the hub and spoke pharmacies, clearly outlining their respective responsibilities.
- The dispensed medicine must be labelled with the spoke’s name and address, and the date on which the hub assembled or part assembled the medicine, along with all the usual information required on a dispensing label.
- Patient data sharing between the hub and spoke is permitted without the patient’s explicit consent through an information gateway, provided appropriate notices are displayed at both hub and spoke sites to maintain the confidentiality of the patient data.
CPE said that they will be providing a briefing on Hub and Spoke dispensing and the new HMR amendments in the coming weeks.
Keep ReadingShow less
Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar
May 01, 2025
The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.
Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.
Out of 88,248 incidents reported to the Metropolitan Police, just 4,629 resulted in charges.
Leicestershire police recorded the lowest charge rate for shoplifting in the country—only 4.5 per cent of 8,345 reported offences led to a suspect being charged.
Humberside police had the highest rate of solved shoplifting cases, charging suspects in 31 per cent of incidents, followed closely by Norfolk Police at 30 per cent.
Across England and Wales, just 18 per cent of the recorded 516,791 shoplifting offences led to a suspect being charged, a marginal increase from 17 per cent the year prior.
The situation is even more concerning for burglary offences.
Less than one in 20 burglaries resulted in a charge last year, with only 7,761 suspects charged out of 172,544 reported incidents—just 4.5 per cent. This marks a drop from the previous year’s 5.2 per cent of the 185,683 burglary crimes.
Derbyshire Police recorded the worst performance for solving burglaries, with just 2 per cent of cases resulting in charges.
Other forces with similarly low outcomes include Hertfordshire (2.11 per cent), Leicestershire (2.56 per cent), Sussex (2.64 per cent), and Gloucestershire (2.86 per cent).
Sir Ed Davey, the Liberal Democrat leader, condemned the figures, telling The Times, “It is shocking that crimes like burglaries and shoplifting are being effectively decriminalised, leaving local communities to pay the price.”
The party has warned that Labour’s failure to properly fund police forces would lead to even more crimes going unsolved.
The Labour government has announced a £1.1 billion boost for police forces across England and Wales for 2025–26, bringing total funding to £19.6 billion.
However, forces have argued that the rise falls short of what is needed to make up for years of underinvestment, increasing demands on officers, and above-inflation pay rises.
In February, prime minister Keir Starmer announced the scrapping of the “shoplifters’ charter” as part of efforts to crack down on retail crime and prevent repeat offences.
Criticising the previous Conservative government, Starmer said: “The opposite party left us with rising crime and effectively told police to ignore shoplifting under £200 worth of goods.
“We’ve got rid of that shoplifters’ charter and we’re working hard to make sure we get a grip where they lost control.”
As part of the government’s wider crackdown on retail crime, ministers have also pledged to introduce a new stand-alone offence for assaulting shop workers.
Keep ReadingShow less
The programme is designed to support pharmacists delivering the Pharmacy Independent Prescribing Service in Wales.
gettyimages
Independent prescribing learning programme for pharmacists in Wales extended till 2028
May 01, 2025
The Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) have announced a three-year extension of their successful learning programme designed to support pharmacists delivering the Pharmacy Independent Prescribing Service (PIPS) in Wales.
Originally launched in 2024, the programme equips pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care as independent prescribers.
The extended partnership means the programme will continue to run until at least 2028.
“We are thrilled to continue and build upon this collaboration with HEIW as we embark on a new 3-year journey to further empower pharmacists across Wales to deliver high-quality prescribing services to our communities,” said Elen Jones, RPS Director for England and Wales.
“This extended partnership builds on the success of last year’s work and reflects the ongoing commitment to advancing the role of prescribing pharmacists.”
The programme offers practical, clinically focused workshops across Wales, designed by experienced pharmacist prescribers and GPs.
The sessions address common conditions seen in community pharmacy and include case studies, group activities, and expert-led Q&A discussions.
Margaret Allan, Pharmacy Dean at HEIW, commented: “We are pleased to be able to build on our collaboration with RPS by continuing the HEIW/ RPS Independent Prescriber Series aimed at Pharmacists accredited to provide the PIPS within Wales.”
“Feedback from the programme in 2024/25 has been overwhelmingly positive and many participants have reported an increase in knowledge, skills and confidence when supporting patients after attendance at an event.”
Allan also shared their plans to increase the number of places available and offer more local events to improve equity of access to PIPS provision across Wales.
Keep ReadingShow less
NPA’s first female vice-chair vows to “open doors” for next generation
Apr 30, 2025
The National Pharmacy Association’s (NPA) new vice-chair has vowed to be an “advocate” for community pharmacy and see the sector get the recognition it deserves.
Sukhi Basra created history this week when she became the first female vice-chair of the NPA and she is determined to ensure she makes a lasting change in her new role.
“Becoming the first female Vice Chair of the National Pharmacy Association is a moment I never imagined writing about, yet here I am, filled to the brim with gratitude, humility, and awe,” Basra wrote on LinkedIn.
“To the Community Pharmacists I now have the honour of representing, I see you. I am you. Hard-working, under-recognised, fiercely dedicated professionals who hold entire communities together with strength, skill, and compassion.
“It is my privilege to advocate for you, challenge for you, and speak truth to power in the rooms where decisions are made.”
Basra will work alongside new NPA chair Olivier Picard as well as the rest of the NPA board which now compromises four female members.
“With four amazing female board members now standing side by side, first Sehar Shahid, then Aisling O'Brien, and finally Joanne Mcmullan, I was no longer alone! I walk forward with Olivier Picard, our Chair, my friend, my partner in crime, whose passion inspires me endlessly,” said Basra.
Basra has owned CliniChem Pharmacy in Victoria, London, for more than 25 years.
She was the second woman ever to be elected to the NPA board and used her position to champion for community pharmacy.
She has written for the likes of The New Statesman looking at how community pharmacies are one of the four key pillars of the primary care system in England, alongside general practice (GP), dentistry and eyecare services.
“This is not the end of anything. This is a beginning and one I step into with mindful intention, fierce kindness, creative courage, and deep gratitude,” said Basra.
“May I never forget why I started. May I always honour the trust placed in me. And may we, together, continue to open the doors wider for those yet to come.”
Keep ReadingShow less
Load More
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc